- Drug Pipelines
- January 2018
- 13 Pages
Global
From €9730EUR$10,000USD£8,335GBP
The AS03 adjuvant market is a segment of the vaccine industry that focuses on the development and production of adjuvants. Adjuvants are substances that are added to vaccines to enhance their effectiveness. AS03 is a specific type of adjuvant that is used in combination with antigens to create a more potent immune response. It is composed of a mixture of squalene oil, DL-alpha-tocopherol, and polysorbate 80. AS03 is used in a variety of vaccines, including those for influenza, human papillomavirus, and hepatitis B.
The AS03 adjuvant market is a rapidly growing segment of the vaccine industry, driven by the increasing demand for more effective vaccines. This demand is driven by the need to protect against a wide range of infectious diseases, as well as the emergence of new diseases.
Some of the major companies in the AS03 adjuvant market include GlaxoSmithKline, Sanofi Pasteur, Merck, and Pfizer. These companies are involved in the development, production, and marketing of AS03 adjuvants for use in vaccines. Show Less Read more